Apr 03, 2023

Companies to Focus on Therapeutic Targets Showing Cause and Effect

Aitia has been featured in Huntington’s Disease News for its collaboration with UCB to develop a new treatment for Huntington’s disease. The article highlights Aitia’s expertise in Causal AI as “a new branch of artificial intelligence that goes beyond establishing links between variables: It makes decisions and predictions based on cause and effect.”

The collaboration with UCB demonstrates Aitia’s commitment to advancing the treatment of Huntington’s disease and improving the lives of those affected by this debilitating condition.

Read Huntington’s Disease News full article here.